GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.
Conference Details: | |
Fireside Chat | |
Date: | Thursday, June 4, 2026 |
Time: | 10:30 – 11:00 a.m. Eastern Time |
Location: | New York, NY |
Recordings
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
[email protected]
Media
Yvonne Sprow
844-264-8571
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-2026-jefferies-global-healthcare-conference-302787486.html